Seeking Alpha

Bausch + Lomb acquires ISTA Pharmaceuticals (ISTA) for $500M, or $9.10 per share in cash. The...

Bausch + Lomb acquires ISTA Pharmaceuticals (ISTA) for $500M, or $9.10 per share in cash. The transaction is expected to strengthen Bausch + Lomb's overall product pipeline and is expected to close in 2Q12.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector